Related Experiment Video

Updated: Aug 23, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty

Gülay Yetkin1, Ertan Yetkin, Yüksel Aksoy

  • 1Department of Microbiology, Inonu University Faculty of Medicine, Malatya, Turkey. eryetkin@ttnet.net.tr

International Journal of Cardiology
|June 15, 2004
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) significantly increased Chlamydia pneumoniae antibodies in patients previously seronegative for IgG. This suggests PTCA may influence the immune response to this common infectious agent.

Area of Science:

  • Infectious disease
  • Cardiovascular medicine
  • Immunology

Background:

  • Chlamydia pneumoniae is increasingly implicated in atherosclerosis pathogenesis.
  • Evidence for C. pneumoniae's role includes sero-epidemiological studies, plaque analysis, and animal models.
  • The impact of medical procedures on immune responses to C. pneumoniae is an area of ongoing research.

Purpose of the Study:

  • To investigate if percutaneous transluminal coronary angioplasty (PTCA) influences humoral immune responses to Chlamydia pneumoniae antigens.
  • To assess changes in specific antibody titers post-PTCA.
  • To identify patient groups exhibiting altered immune responses after PTCA.

Main Methods:

  • A prospective study of 76 patients undergoing PTCA for de novo lesions.
  • Blood samples collected immediately before and 1 month after PTCA.
  • Quantification of IgG and IgA antibodies against C. pneumoniae using a custom enzyme immunoassay.

Main Results:

  • A significant increase in C. pneumoniae IgG and IgA antibody titers was observed in patients seronegative for IgG before PTCA.
  • 88% of previously seronegative patients became seropositive for IgG post-PTCA.
  • No significant changes in antibody levels were noted in patients already seropositive for IgG before PTCA.

Conclusions:

  • PTCA induces a statistically significant rise in C. pneumoniae antibodies, particularly IgG, in previously seronegative patients.
  • The angioplasty procedure appears to modulate the immune response to C. pneumoniae.
  • These findings highlight a potential link between interventional cardiology procedures and infectious agent-related immune responses.
Abstract

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...